Semaglutide: A Game-Changer in Reducing All-Cause Hospital Admissions
Exploring the Impact of Semaglutide on Hospital Admissions and Healthcare Costs
Recently, semaglutide has become the potent drug to treat diabetes and obesity as well. Originally created as an antidiabetic drug for the type 2, semaglutide also gained its application in the treatment of obesity owing to its ability to lead to weight loss. In addition to its major functions, a study from the SELECT phase 3 trial suggests that semaglutide can lower hospitalization for any cause, which expands the implications of the drug to health systems.
Overview of Semaglutide
Mechanism of Action
Semaglutide is an drug belonging to the class of glucagon-like peptide-1 (GLP-1) receptor agonist. It is modeled on the GLP-1 hormone, of which the human body generates to control appetite and blood sugar. Semaglutide also increases insulin output when blood glucose is elevated, decreases glucagon output and output slows down the rate at which stomach empties, therefore lowering blood glucose. It also affects the brain that is responsible for appetite and induces satiety with leads to permanently effecting the loss of weight.
